S. 5059 has not moved since its introduction on Jul 21, 2026, with cosponsors from both parties
A bill to amend the Public Health Service Act to streamline the review of biosimilar biological products.
IntroducedJul 21, 2026
Reported—
Passed one chamber—
Passed both—
Law—
What it changes · CRS summary
CRS has not published a summary of this bill yet. Read the bill text.
Context
- Committees
- Senate Health, Education, Labor, and Pensions Committee
- Policy area
- Health: 122 of 9,357 bills became law, 113th–118th (1.3%)
- Sponsor
- 0 of 53 bills enacted since 2013
- Text versions
- 1: introduced in senate · 33 words
- Latest action
- Jul 21, 2026: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Records
- Congress.gov · Bill text
Exhibit 1Passage odds band at each stage, rated when the bill reached it [4]
Related bills · 2
Each bill appears once, under its strongest link. 2 in all.
Related, per CRS or House · 2
- 119th H.R. 9661 Expedited Access to Biosimilars Act R · Introduced
- 119th S. 1414 Expedited Access to Biosimilars Act R · Reported
Exhibit 2Articles naming the bill per day, last 90 days, US sources [3]